Stifel maintains Immunome at Hold, lowers price target to $23 from $24
Stifel downgraded Immunome's price target to $23 from $24, a 4.2% decrease. This implies an 18.8% upside from the Nov 9 close of $19.36. Recent analyst targets range from $30 to $35.
